Vaccination with poly(IC:LC) and peptide-pulsed autologous Dendritic cells in Patients with Pancreatic Cancer

2021-12-05T10:20:39+00:00December 5th, 2021|

Vaccination with poly(IC:LC) and peptide-pulsed autologous Dendritic cells in Patients with Pancreatic Cancer CT scan. CONTACT US Summary This study investigates, DC-based immunotherapy, in conjunction with toll-like receptor (TLR)-3 [...]

A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin� 2

2021-12-05T07:14:34+00:00November 30th, 2021|

A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin 2 Overall survival rate CONTACT US Summary [...]

Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02)

2021-12-01T05:59:50+00:00November 30th, 2021|

Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02) Overall survival rate CONTACT US Summary The data aims to examine patients with platinum-sensitive ovarian [...]

Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial

2021-11-22T10:55:34+00:00November 19th, 2021|

Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial Change in expression CONTACT US Summary This study examines patients with Glioblastoma multiforme (GBM) [...]

Autologous Dendritic Cell-based Immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in Advanced Non-Small Cell Lung Cancer: A randomized, open-label, phase I/II trial

2021-11-22T10:57:24+00:00November 19th, 2021|

Autologous Dendritic Cell-based Immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in Advanced Non-Small Cell Lung Cancer: A randomized, open-label, phase I/II trial Survival rate CONTACT US Summary The study aims to [...]

A phase-1/2 study of adenovirus-p53 transduced Dendritic Cell Vaccine in combination with Indoximod in metastatic solid tumors and invasive Breast Cancer

2021-11-22T14:44:11+00:00November 19th, 2021|

A phase-1/2 study of adenovirus-p53 transduced Dendritic Cell Vaccine in combination with Indoximod in metastatic solid tumors and invasive Breast Cancer Survival rate CONTACT US Summary [...]

Dendritic Cell-based Immunotherapy Pulsed with Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial

2021-11-22T14:47:42+00:00November 19th, 2021|

Dendritic Cell-based Immunotherapy Pulsed with Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial Survival rate CONTACT [...]

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

2021-11-22T10:34:24+00:00November 19th, 2021|

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma Treatment scheme CONTACT US Summary This study focuses on the [...]

Go to Top